Lv41
558 积分 2025-08-11 加入
Targeting the BCKDK/BCLAF1/MYC/HK2 axis to alter aerobic glycolysis and overcome Trametinib resistance in lung cancer
2小时前
待确认
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma
14天前
已完结
Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
14天前
已完结
Multifaceted roles of UFMylation in health and disease
25天前
已完结
TRIM21 and OTUD6A orchestrate AKT K27-linked atypical ubiquitination to modulate cancer chemoresistance
1个月前
已完结
Targeting the BCKDK/BCLAF1/MYC/HK2 axis to alter aerobic glycolysis and overcome Trametinib resistance in lung cancer
1个月前
已完结
Large-scale dependency and drug screens to characterize the therapeutic vulnerabilities of multiple myeloma with 1q+
2个月前
已完结
Ubiquitin-like modification dependent proteasomal degradation and disease therapy
2个月前
已完结
UFMylation: a ubiquitin-like modification
2个月前
已完结
Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy
2个月前
已完结
皖公网安备34019202002308
